Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial

被引：2

作者：

Pfeiler, G.

Koenigsberg, R.

Mlineritsch, B.

Stoger, H.

Singer, C. F.

Poestlberger, S.

Steger, G.

Seifert, M.

Dubsky, P. C.

Jakesz, R.

Samonigg, H.

Bjelic-Radisic, V.

Greil, R.

Marth, C.

Fesl, C.

Gnant, M.

机构：

[1] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria

[2] Inst Translat Res Vienna CEADDP, Vienna, Austria

[3] Paracelsus Univ Salzburg, Salzburg, Austria

[4] Med Univ Klin Graz, Graz, Austria

[5] Med Univ Vienna, Gen Hosp, Vienna, Austria

[6] Hosp Sisters Mercy, Linz, Austria

[7] Med Univ Vienna, Vienna, Austria

[8] Med Univ Vienna, Dept Surg, Vienna, Austria

[9] Med Univ, Dept Internal Med, Graz, Austria

[10] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria

[11] Univ Hosp Salzburg, Dept Med 3, Salzburg, Austria

[12] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria

[13] Austrian Breast & Colorectal Canc Study Grp, Vienna, Austria

[14] Med Univ Vienna, Dept Surg, Ctr Comprehens Canc, Vienna, Austria

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期

关键词：

D O I：

10.1200/jco.2011.29.15_suppl.514

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

514

引用

页数：1

共 50 条

[41] Body mass index and aromatase inhibitors: a step forward in individualizing therapy for breast cancer patients?
Slowik, Agnieszka
Fraczek, Paulina A.
Krzemieniecki, Krzysztof
EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (07) : 759 - 766
[42] Effect of Nutritional Therapy on Body Mass Index of Cancer Patients- A Pilot Study
Sebastian, Shanthi
Shambhavi
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (10) : LC16 - LC19
[43] EFFICACY OF 12-MONTH THERAPY WITH METHOTREXATE SOLUTION FOR SUBCUTANEOUS INJECTION (SC MTX) IN PATIENTS WITH EARLY RA WITH DIFFERENT BODY MASS INDEX (BMI)
Gridneva, G. I.
Muraviev, Y.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1037 - 1037
[44] The effect of body mass index (BMI) on survival in patients with breast cancer and obesity-associated conditions.
Caddell, Keenan B.
Ren, Yi
Sampathkumar, Anuyuga
Almond, Chandra A.
Ladipo, Oluwatomi L.
Champ, Colin E.
Rosenberger, Laura Horst
Greenup, Rachel Adams
Plichta, Jennifer Kay
DiLalla, Gayle
Menendez, Carolyn S.
Tolnitch, Lisa
Hwang, Eun-Sil Shelley
Hyslop, Terry
Fayanju, Oluwadamilola Motunrayo
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
[45] Impact of Body Mass Index (BMI) on the efficacy of different adjuvant chemotherapy schedules in patients with breast cancer: analysis from the randomized phase III GIM2 trial
Poggio, Francesca
Blondeaux, Eva
Tagliamento, Marco
Perachino, Marta
Nardin, Simone
Conte, Benedetta
De Placido, Sabino
Giuliano, Mario
Forestieri, Valeria
De laurentiis, Michelino
Gravina, Adriano
Bisagni, Giancarlo
Rimanti, Anita
Turletti, Anna
Nistico, Cecilia
Vaccaro, Angela
Cognetti, Francesco
Fabi, Alessandra
Gasparro, Simona
Garrone, Ornella
Urracci, Ylenia
Alicicco, Maria Grazia
Mansutti, Mauro
Poletti, Paola
Correale, Pierpaolo
Bighin, Claudia
Puglisi, Fabio
Montemurro, Filippo
Colantuoni, Giuseppe
Boni, Luca
Lambertini, Matteo
Del Mastro, Lucia
CANCER RESEARCH, 2024, 84 (09)
[46] Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium
Shepshelovich, Daniel
Xu, Wei
Lu, Lin
Fares, Aline
Yang, Ping
Christiani, David
Zhang, Jie
Shiraishi, Kouya
Ryan, Brid M.
Chen, Chu
Schwartz, Ann G.
Tardon, Adonina
Wu, Xifeng
Schabath, Matthew B.
Teare, M. Dawn
Le Marchand, Loic
Zhang, Zuo-Feng
Field, John K.
Brenner, Hermann
Diao, Nancy
Xie, Juntao
Kohno, Takashi
Harris, Curtis C.
Wenzlaff, Angela S.
Fernandez-Tardon, Guillermo
Ye, Yuanqing
Taylor, Fiona
Wilkens, Lynne R.
Davies, Michael
Liu, Yi
Barnett, Matt J.
Goodman, Gary E.
Morgenstern, Hal
Holleczek, Bernd
Brown, M. Catherine
Liu, Geoffrey
Hung, Rayjean J.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (09) : 1594 - 1607
[47] Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial
Serena Di Cosimo
Luca Porcu
Dominique Agbor-tarh
Saverio Cinieri
Maria Alice Franzoi
Maria Carmen De Santis
Cristina Saura
Jens Huober
Debora Fumagalli
Miguel Izquierdo
Martine Piccart
Maria Grazia Daidone
Evandro de Azambuja
Breast Cancer Research, 22
[48] Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial
Di Cosimo, Serena
Porcu, Luca
Agbor-Tarh, Dominique
Cinieri, Saverio
Franzoi, Maria Alice
De Santis, Maria Carmen
Saura, Cristina
Huober, Jens
Fumagalli, Debora
Izquierdo, Miguel
Piccart, Martine
Daidone, Maria Grazia
de Azambuja, Evandro
BREAST CANCER RESEARCH, 2020, 22 (01)
[49] Effect of body mass index (BMI) on response to neoadjuvant therapy in human epidermal growth factor receptor 2 (HER2) positive breast cancer (BC): Analysis from NeoALLTO trial
Galli, G.
Bradbury, I.
Cinieri, S.
Agbor-Tarh, D.
De Braud, F. G. M.
Baselga, J.
Huober, J.
Fumagalli, D.
Sarp, S.
Piccart, M.
de Azambuja, E.
Di Cosimo, S.
ANNALS OF ONCOLOGY, 2016, 27
[50] Impact of body mass index on treatment and outcomes in patients with early hormone receptor-positive breast cancer receiving endocrine therapy with or without palbociclib in the PALLAS trial.
Pfeiler, Georg
Hlauschek, Dominik
Mayer, Erica L.
Deutschmann, Christine
Kacerovsky-Strobl, Stephanie
Martin, Miguel
Meisel, Jane Lowe
Zdenkowski, Nicholas
Loibl, Sibylle
Balic, Marija
Park, Haeseong
Prat, Aleix
Isaacs, Claudine
Machacek-Link, Jana
Schurmans, Celine
Theall, Kathy Puyana
Fesl, Christian
Dueck, Amylou C.
DeMichele, Angela
Gnant, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

← 1 2 3 4 5 →